Editorial commentary: protease inhibitor monotherapy: safe for the CNS in durably suppressed patients?
Clin Infect Dis
.
2014 Dec 1;59(11):1635-7.
doi: 10.1093/cid/ciu645.
Epub 2014 Aug 11.
Author
Scott L Letendre
1
Affiliation
1
University of California, San Diego, California.
PMID:
25114033
PMCID:
PMC4650774
DOI:
10.1093/cid/ciu645
No abstract available
Keywords:
CNS; HIV; antiretroviral; dementia.
Publication types
Editorial
Comment
MeSH terms
Cognition Disorders / virology*
Female
HIV Infections / drug therapy*
HIV Protease Inhibitors / administration & dosage*
Humans
Male
Substances
HIV Protease Inhibitors
Grants and funding
K24 MH097673/MH/NIMH NIH HHS/United States
P30 MH062512/MH/NIMH NIH HHS/United States